Literature DB >> 16401428

High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans.

Sara L Sawyer1, Lily I Wu, Joshua M Akey, Michael Emerman, Harmit S Malik.   

Abstract

The intracellular TRIM5alpha protein successfully inhibits HIV-1 infection in rhesus monkeys, but not in humans . A few amino acids in the virus-interacting SPRY domain were found to be responsible for most of this anti-viral specificity , raising the possibility that genetic variation among humans could result in TRIM5alpha proteins with a spectrum of potencies. We found several nonsynonymous SNPs at the human TRIM5 locus, but only one of these (H43Y) was found to have a significant functional consequence. We demonstrate that H43Y impairs TRIM5alpha restriction of two distantly related retroviruses. H43Y lies in the RING domain of TRIM5alpha and may negatively affect its putative E3 ubiquitin ligase activity. This detrimental allele dates back to before the African diaspora and is found at a frequency of 43% in indigenous Central and South Americans. We suggest that relaxed constraint due to a recent period of low retroviral challenge has allowed the deleterious H43Y mutation to persist and even to expand after the bottleneck that occurred upon human migration to the New World. The unexpectedly high frequency of an impaired retroviral restriction allele among humans is likely to have a significant impact on our ability to ward off future retroviral challenges.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401428     DOI: 10.1016/j.cub.2005.11.045

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  62 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

3.  How TRIM5alpha defends against retroviral invasions.

Authors:  Michael Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha.

Authors:  Ruchi M Newman; Laura Hall; Michelle Connole; Guo-Lin Chen; Shuji Sato; Eloisa Yuste; William Diehl; Eric Hunter; Amitinder Kaur; Gregory M Miller; Welkin E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

5.  The retroviral restriction factor TRIM5alpha.

Authors:  Sarah Sebastian; Jeremy Luban
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

Review 6.  Vaccinomics: current findings, challenges and novel approaches for vaccine development.

Authors:  Inna G Ovsyannikova; Gregory A Poland
Journal:  AAPS J       Date:  2011-06-14       Impact factor: 4.009

Review 7.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

8.  Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Neelam Dhiman; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  An expanded clade of rodent Trim5 genes.

Authors:  Semih U Tareen; Sara L Sawyer; Harmit S Malik; Michael Emerman
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

10.  Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; Megan M O'Byrne; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2009-11-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.